News & Updates
Filter by Specialty:
Glycaemic control not a risk factor for cerebral small vessel disease in T1D
Among patients with type 1 diabetes (T1D), medium- and long-term blood glucose control and long-term glycaemic variability do not exert any influence on the risk of developing cerebral small vessel disease, a study has found.
Glycaemic control not a risk factor for cerebral small vessel disease in T1D
16 Mar 2022
Thrombectomy safe for paediatric stroke patients
In the treatment of children with acute ischaemic stroke, endovascular thrombectomy is safe and results in high rates of achieving favourable functional outcomes, as shown in a study.
Thrombectomy safe for paediatric stroke patients
16 Mar 2022
Early menopause tied to increased dementia risk
Individuals who experience menopause before age 50 years may be at an elevated risk of developing dementia, according to results of a UK study presented at the EPI Lifestyle Scientific Sessions 2022.
Early menopause tied to increased dementia risk
15 Mar 2022
Corticosteroids help prevent hearing loss, neurologic sequelae in paediatric bacterial meningitis
Children with bacterial meningitis appear to fare well with corticosteroids, which lead to a lower incidence of hearing loss and neurologic sequelae and faster resolution of fever, according to a meta-analysis.
Corticosteroids help prevent hearing loss, neurologic sequelae in paediatric bacterial meningitis
15 Mar 2022
T2D: Risk of CV and all-cause mortality lower with SGLT2 vs DPP-4 inhibitors
A real-world propensity score-matched study in Hong Kong finds that, compared with use of dipeptidyl peptidase-4 (DPP-4) inhibitors, use of sodium-glucose cotransporter 2 (SGLT2) inhibitors in type 2 diabetes (T2D) patients is associated with lower risk of incident atrial fibrillation (AF), stroke/transient ischaemic attack (TIA), and cardiovascular (CV) and all-cause mortality.